|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
symbol(s)
|
Name of each exchange
on which registered
|
||
|
|
|
Item 8.01 |
Other Events.
|
AVROBIO, INC.
|
||
Date: June 13, 2023
|
By:
|
/s/ Erik Ostrowski
|
Erik Ostrowski
|
||
President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer
|
Document and Entity Information |
Jun. 12, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jun. 12, 2023 |
Entity File Number | 001-38537 |
Entity Registrant Name | AVROBIO, INC. |
Entity Central Index Key | 0001681087 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 81-0710585 |
Entity Address, Address Line One | 100 Technology Square |
Entity Address, Address Line Two | Sixth Floor |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02139 |
City Area Code | 617 |
Local Phone Number | 914-8420 |
Title of 12(b) Security | Common Stock, $0.0001 par value per share |
Trading Symbol | AVRO |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
_>V'9O
MS?6&*P3:C+HU4KART^&?